bioAffinity Technologies, Inc. 8-K

What Happened

• bioAffinity Technologies, Inc. filed a Current Report on Form 8‑K dated February 10, 2026 to disclose that management has prepared presentation materials the company will use in presentations about its operations and performance.
• The presentation materials were posted to the company’s website on February 10, 2026 and are furnished as Exhibit 99.1 to the 8‑K. The disclosure was made under Regulation FD to ensure broad public distribution.

Key Details

• Filing date: February 10, 2026.
• Exhibit furnished: 99.1 — Presentation Materials (February 2026).
• Disclosure type: Regulation FD (Regulation Fair Disclosure) presentation posted on company website.
• Company form filed: Current Report on Form 8‑K (Reg FD disclosure and exhibits).

Why It Matters

• The posted investor presentation gives all investors access to the same management materials about the company’s operations and performance, which can provide updated context for evaluating the business.
• Because the material was furnished under Regulation FD, it signals the company intended this information for broad public release rather than selective disclosure to analysts or institutional investors.